Thursday, August 13, 2020

Micronoma Finds $3M For Early Cancer Detection

San Diego-based Micronoma, a startup working on early cancer detection, announced this morning that it has raised $3M in a seed financing round. The funding was led by SymBiosis, LLc. According to the company, it will use the funding to further advance its cancer detection technology. Micronoma said it is working on developing and commercializing a minimally invasive, microbiome-based method of early cancer detection. The company was founded by Sandrine Miller-Montgomery, CEO of Micronoma, previously Executive Director of the Center for Microbiome Innovation; Dr. Rob Knight, Director of the Center for Microbiome Innovation at the University of California San Diego (UC San Diego) and Greg Poore, an M.D.-Ph.D. candidate at UC San Diego School of Medicine.